Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xingqiang Wang, Shanshi Wang, Xiaolong Li, Shigang Jin, Feng Xiong & Xin Wang. (2017) The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma. OncoTargets and Therapy 10, pages 2781-2789.
Read now
Read now
Carlo Genova, Erika Rijavec, Giulia Barletta, Giovanni Burrafato, Federica Biello, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Angela Alama, Francesco Boccardo & Francesco Grossi. (2014)
Afatinib for the treatment of advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 15:6, pages 889-903.
Read now
Read now
Fei-fei Teng, Jian-dong Zhang, Xue Meng & Jin-ming Yu. (2014) Reversion of erlotinib-acquired resistance twice by chemotherapy. Cancer Biology & Therapy 15:2, pages 172-177.
Read now
Read now
BRUNA COROMINAS-FAJA, Cristina Oliveras-Ferraros, ELISABET CUYÀS, Antonio Segura-Carretero, Jorge Joven, Begoña Martin-Castillo, ENRIQUE BARRAJÓN-CATALÁN, Vicente Micol, Joaquim Bosch-Barrera & JAVIERABEL MENENDEZ MENENDEZ. (2013) Stem cell-like ALDHbright cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin. Cell Cycle 12:21, pages 3390-3404.
Read now
Read now
Sabrina Vari, Sara Pilotto, Marcello Maugeri-Saccà, Ludovica Ciuffreda, Ursula Cesta Incani, Italia Falcone, Anais Del Curatolo, Anna Ceribelli, Alain Gelibter, Ruggero De Maria, Giampaolo Tortora, Francesco Cognetti, Emilio Bria & Michele Milella. (2013) Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. Expert Opinion on Drug Discovery 8:11, pages 1381-1397.
Read now
Read now
Vincenzo Carafa, Marco Miceli, Lucia Altucci & Angela Nebbioso. (2013) Histone deacetylase inhibitors: a patent review (2009 – 2011). Expert Opinion on Therapeutic Patents 23:1, pages 1-17.
Read now
Read now
Articles from other publishers (21)
Masafumi Noguchi, Susumu Kohno, Anna Pellattiero, Yukino Machida, Keitaro Shibata, Norihito Shintani, Takashi Kohno, Noriko Gotoh, Chiaki Takahashi, Atsushi Hirao, Luca Scorrano & Atsuko Kasahara. (2023) Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line. Cell Death & Disease 14:4.
Crossref
Crossref
Jiahui Wu, Xiao He, Ziwei Xiong, Lingyu Shi, Daofeng Chen, Yulin Feng & Quan Wen. (2022) Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling. Frontiers in Oncology 12.
Crossref
Crossref
Zixin Xie, Kaiqi Wu, Yuexuan Wang, Yaqian Pan, Bo Chen, Donghua Cheng, Suwei Pan, Taoning Guo, Xuze Du, Longcheng Fang, Xuebao Wang & Faqing Ye. (2020) Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC. European Journal of Medicinal Chemistry 187, pages 111943.
Crossref
Crossref
Supaphorn Seetaha, Siriluk Ratanabanyong & Kiattawee Choowongkomon. (2019) Expression, purification, and characterization of the native intracellular domain of human epidermal growth factor receptors 1 and 2 in Escherichia coli. Applied Microbiology and Biotechnology 103:20, pages 8427-8438.
Crossref
Crossref
Duc-Hiep Bach, Thi-Thu-Trang Luu, Donghwa Kim, Yong Jin An, Sunghyouk Park, Hyen Joo Park & Sang Kook Lee. (2018) BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells. Molecular Therapy - Nucleic Acids 12, pages 817-828.
Crossref
Crossref
Marzieh Badinloo & Saeed Esmaeili Mahani. (2016) Combined Application of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Inhibitors Suppresses Cell Growth and Promotes Apoptosis in Human Lung Cancer Cell Lines. Iranian Journal of Cancer Prevention In Press:In Press.
Crossref
Crossref
Sidra Younis, Qamar Javed & Miroslav Blumenberg. (2015) Transcriptional changes associated with resistance to inhibitors of epidermal growth factor receptor revealed using metaanalysis. BMC Cancer 15:1.
Crossref
Crossref
Asuka Nakata, Ryo Yoshida, Rui Yamaguchi, Mai Yamauchi, Yoshinori Tamada, Andre Fujita, Teppei Shimamura, Seiya Imoto, Tomoyuki Higuchi, Masaharu Nomura, Tatsuo Kimura, Hiroshi Nokihara, Masahiko Higashiyama, Kazuya Kondoh, Hiroshi Nishihara, Arinobu Tojo, Seiji Yano, Satoru Miyano & Noriko Gotoh. (2015) Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports 5:1.
Crossref
Crossref
Meagan B Myers, Karen L McKim, Fanxue Meng & Barbara L Parsons. (2015)
Low-frequency
KRAS
mutations are prevalent in lung adenocarcinomas
. Personalized Medicine 12:2, pages 83-98.
Crossref
Crossref
Youzhi Li, Harry A. Rogoff, Sarah Keates, Yuan Gao, Sylaja Murikipudi, Keith Mikule, David Leggett, Wei Li, Arthur B. Pardee & Chiang J. Li. (2015) Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proceedings of the National Academy of Sciences 112:6, pages 1839-1844.
Crossref
Crossref
Eric Bradley, Somsankar Dasgupta, Xue Jiang, Xiaying Zhao, Gu Zhu, Qian He, Michael Dinkins, Erhard Bieberich & Guanghu Wang. (2014) Critical Role of Spns2, a Sphingosine-1-Phosphate Transporter, in Lung Cancer Cell Survival and Migration. PLoS ONE 9:10, pages e110119.
Crossref
Crossref
Jun-Min Shi, Hui-Juan Huang, Sheng-Xiang Qiu, Shi-Xiu Feng & Xu-E Li. (2014) Griffipavixanthone from Garcinia oblongifolia Champ Induces Cell Apoptosis in Human Non-Small-Cell Lung Cancer H520 Cells in Vitro. Molecules 19:2, pages 1422-1431.
Crossref
Crossref
F. Éberlé. (2013) Caractérisation des principaux biomarqueurs prédictifs de réponse aux thérapies ciblées en oncologie thoracique. Annales Pharmaceutiques Françaises 71:6, pages 369-375.
Crossref
Crossref
Sílvia Cufí, Rosa Bonavia, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Bruna Corominas-Faja, Elisabet Cuyàs, Begoña Martin-Castillo, Enrique Barrajón-Catalán, Joana Visa, Antonio Segura-Carretero, Jorge Joven, Joaquim Bosch-Barrera, Vicente Micol & Javier A. Menendez. (2013) Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo. Scientific Reports 3:1.
Crossref
Crossref
James P. DeanCynthia C. SprengerJunxiang WanKathleen HaugkWilliam J. EllisDaniel W. LinJohn M. Corman, Bruce L. DalkinElahe MostaghelPeter S. NelsonPinchas CohenBruce MontgomeryStephen R. Plymate. (2013) Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation. The Journal of Clinical Endocrinology & Metabolism 98:5, pages E820-E828.
Crossref
Crossref
Kaid Darwiche, Paul ZarogoulidisNikos K Karamanos, Kalliopi Domvri, Ekaterini Chatzaki, Theodoros C Constantinidis, Stylianos Kakolyris & Konstantinos Zarogoulidis. (2013) Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology. Future Oncology 9:4, pages 505-525.
Crossref
Crossref
Ya-Fei Zhu, Guo-Lan Gao, Sheng-Bo Tang, Zhen-Dong Zhang & Qing-Shui Huang. (2013) Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro. Asian Pacific Journal of Tropical Medicine 6:4, pages 265-272.
Crossref
Crossref
Véronique Mathieu, Nathalie Wauthoz, Florence Lefranc, Hendrik Niemann, Karim Amighi, Robert Kiss & Peter Proksch. (2013) Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules 18:3, pages 3543-3561.
Crossref
Crossref
Meizhi Wu, Lin Zhao, Lei Zhu, Zhange Chen & Huangjin Li. (2013) Expression and purification of chimeric peptide comprising EGFR B-cell epitope and measles virus fusion protein T-cell epitope in Escherichia coli. Protein Expression and Purification 88:1, pages 7-12.
Crossref
Crossref
Sei-Hoon Yang. (2013) Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors. Tuberculosis and Respiratory Diseases 75:5, pages 188.
Crossref
Crossref
Takuya ArakiHideaki YashimaKimihiro ShimizuTohru AomoriTadahiro HashitaKyoichi KairaTomonori NakamuraKoujirou Yamamoto. (2012) Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib. Clinical Medicine Insights: Oncology 6, pages CMO.S7340.
Crossref
Crossref